Eurofins Pharma Bioanalytical Services launches new Consulting Business

Kristy Galkowski, Marketing Manager, Eurofins Pharma Bioanalytics Services US, KristenGalkowski@eurofins.com

Capitalising on a growing client need for access to high levels of large molecule GLP expertise for special, often short-term, consults when it is not feasible to utilise in-house experts, Eurofins Pharma Bioanalytical Services has established a new service line to provide the quality and regulatory expertise and experience required in conducting and reporting new drug clinical study results to regulatory agencies in both the US and EU. Backed by 15 years of experience, Eurofins Bioanalytical Consulting offers a wide range of consulting services in support of proposed and ongoing large molecule bioanalysis.

Eurofins provides on-site or remote scientific resources to meet in-house bioanalytical needs or to resolve issues. The team can develop a comprehensive bioanalytical programme for drug candidates, provide method troubleshooting services, monitor and review method validation and sample analysis activities, perform prequalification and final study data audits. Working in tandem with clients, Eurofins Consulting strives to ensure that bioanalytical methods, processes and data are scientifically sound, accurate, and suitable for regulatory submission.

Delivering scientific expertise, training to improve assay ruggedness and increase laboratory efficiencies, Eurofins is dedicated to meet clients’ rigorous needs with an emphasis on the design of large molecule bioanalytical programmes, preparation of protocol synopses, and development of reports at various levels of detail summarising findings. Combining technical knowledge, capacity, regulatory expertise and global presence, Eurofins Consulting is uniquely qualified to provide clients with the reliability they can trust.

For more information, visit www.eurofins.com/biopharma-services/bioanalysis/